Fig. 5

Landmark survival analysis of 28-day mortality with combined SHR and GV assessment in Pre-DM patients. Low SHR: SHR < 1.15; High SHR: SHR > 1.15; Low GV: GV < 24.46; High GV: GV > 24.46
Landmark survival analysis of 28-day mortality with combined SHR and GV assessment in Pre-DM patients. Low SHR: SHR < 1.15; High SHR: SHR > 1.15; Low GV: GV < 24.46; High GV: GV > 24.46